Compounds > imiquimod
Page last updated: 2024-08-24

imiquimod and Keratosis, Oral

imiquimod has been researched along with Keratosis, Oral in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aneiros-Fernandez, J; Blasco-Morente, G; Martinez-Lopez, A; Naranjo-Diaz, MJ; Perez-Lopez, I; Ruiz-Villaverde, R; Tercedor-Sanchez, J1
Cunningham, LL; Dziubla, TD; Puleo, DA; Ramineni, SK1
Allam, JP; Appel, TR; Bieber, T; Erdsach, T; Novak, N; Wenghoefer, M1

Other Studies

3 other study(ies) available for imiquimod and Keratosis, Oral

ArticleYear
Successful treatment of proliferative verrucous leukoplakia with 5% topical imiquimod.
    Dermatologic therapy, 2017, Volume: 30, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Female; Humans; Imiquimod; Leukoplakia, Oral; Treatment Outcome

2017
Development of imiquimod-loaded mucoadhesive films for oral dysplasia.
    Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:2

    Topics: Adhesives; Aminoquinolines; Animals; Cell Line; Chemistry, Pharmaceutical; Drug Delivery Systems; Imiquimod; Leukoplakia, Oral; Mice

2013
Successful treatment of extensive human papillomavirus-associated oral leucoplakia with imiquimod.
    The British journal of dermatology, 2008, Volume: 158, Issue:3

    Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Female; Humans; Imiquimod; Leukoplakia, Oral; Middle Aged; Papillomavirus Infections; Secondary Prevention; Treatment Outcome

2008